NRXN1 and breast cancer: To examine the function of miRNA-495, NRXN-1, and CNTN-1 as predictive/prognostic biomarker for BC patients, TNM stages were categorized into two groups (early stage and advanced stage) and ROC curves analysis was performed (Table 5).